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PAPER DISCUSSION
Background: We report a prospective randomised
comparison between laparoscopic and small-incision
cholecystectomy in 200 patients which was designed
to eliminate bias for or against either technique.
Methods: Patients were randomised in the oper-
ating theatre and anaesthetic technique and
pain-control methods were standardised. Four
experienced surgeons did both types of procedure.
Identical wound dressings were applied in both
groups so that carers could be kept blind to the
type of operation.
Findings: There was no significant difference be-
tween the groups for age, sex, body mass index, and
American Society of Anaesthesiologists grade.
Laparoscopic cholecystectomy took significantly
longer than small-incision cholecystectomy (median
65 [range 27-140] min vs 40 [18-142] min, p<0.001).
The operating time included operative cholangio-
graphy which was attempted in all patients. We
found no significant difference between the groups
for hospital stay (postoperative nights in hospital,
median 3.0 [1-17] nights for laparoscopic vs 3.0
[1-14] nights for small-incision, p=0.74), time back
to work for employed persons (median 5.0 weeks vs
4.0 weeks; p=0.39), and time to full activity (median
3.0 weeks vs 3.0 weeks; p=0.15).
Interpretation: Laparoscopic cholecystectomy takes
longer to do than small-incision cholecystectomy
and does not have any significant advantages in
terms of hostital stay or 13ostoperative recovery.
Laparoscopic cholecystectomy serves as the
prototype success story for the introduction of
minimally invasive surgery into the mainstream
practice of surgery world wide. This study by
Majeed et al. recruited 200 patients over a three
and one-half year period with symptomatic
gallstones. Patients were randomized intra-
operatively after the induction of anesthesia to
undergo either standard laparoscopic cholecys-
tectomy with an attempt at routine operative
cholangiography, or "small-incision" cholecys-
tectomy. The small incision used in this study
was a high transverse sub-xiphoid incision,
dividing the rectus muscle as needed, and
dissecting the gallbladder from Calot’s triangle
toward the fundus with long instruments,
avoiding the insertion of hands into the
peritoneal cavity. An important aspect of this
study is that the patients were treated post-
operatively with a patient-controlled analgesic
system delivering morphine, and that the
patients were "told that they could get out of
bed and go home as soon as they felt fitHPB INTERNATIONAL 339
enough". Additionally, patients Were "given no
advice on how long they would expect to
remain convalescent".
While initially 100 patients were randomized
to the laparoscopic and "small-incision" arms
respectively, 20 patients in the laparoscopic
group were converted to open cholecystectomy
and there was one bile duct injury in the
laparoscopic cholecystectomy group. The medi-
an length of the incision in the "small-incision"
group was 7 cm, ranging from 4 cm to 18 cm.
Comparative data for all patients randomized to
the laparoscopic versus "small-incision" groups
(100 in each group) indicated that the operating
time of 69 minutes was significantly longer in
the laparoscopic group as compared to 45
minutes in the "small-incision" group. Addi-
tionally, the time to first feeding was 24.7
hours in the laparoscopic group versus 22.4
hours in the "small-incision" group, a differ-
ence which achieves statistical significance, but
is of course meaningless. There were no
significant differences in the hospital stay
(approximately 3.5 nights in each group), time
off work (approximately 41/2 to 5 weeks in each
group), and the length of time required to
return to full activity, (approximately 4 weeks
in both groups).
The authors are to be congratulated for
conducting this study which compares laparo-
scopic to "small-incision" cholecystectomy.
While their data indicate that laparoscopic
cholecystectomy requires additional operative
time, their findings that it confers no benefit over
"small-incision" cholecystectomy in terms of
postoperative recovery, hospital stay and time
back to work may not be applicable to patients
in other settings, other countries, or patients
operated upon outside of the British Health
Service. For example, the policy of "self deter-
mination" used in this study regarding the
patient’s timing of ambulation and hospital
discharge is not applicable to the vast majority
of patients who undergo laparoscopic cholecys-
tectomy in the United States. Laparoscopic
cholecystectomy in the U.S. is typically attended
by no more than a one night hospital stay, and in
many settings is now performed as an outpatient
procedure, with the patient being discharged
on the same day as the procedure. Such an
approach requires preoperative patient educa-
tion, appropriate patient expectations, modifica-
tions in the anesthetic and analgesic regimens (to
avoid the use of emesis-associated drugs), as
well as the use of in- filtrative local anesthetics to
reduce the pain associated with the laparoscopic
incisions.
Several studies have now been reported
comparing laparoscopic to open or "small-
incision" cholecystectomy [1, 2, 3]. Additionally,
laparoscopic and "small-incision" cholecystec-
tomy have been compared using linear analogue
pain scores, consumption of postoperative pa-
tient-controlled morphine, and pulmonary func-
tion [4]. A recent review of over 5,000 patients
who underwent laparoscopic cholecystectomy
in the U.S. Department of Defense Health Care
System (at 89 military medical treatment facil-
ities) indicated that the median length of stay for
patients following laparoscopic cholecystectomy
was one day [5], results identical to many of the
recently published U.S. studies.
Majeed and coauthors are to be congratulated
in performing a well designed study which
compared laparoscopic to "small-incision" chol-
ecystectomy within the structured confines of
the trial design. While their data undoubtedly
indicate that laparoscopic cholecystectomy uti-
lizes more operative time than "small-incision"
cholecystectomy, their conclusions that it has no
advantages in terms of hospital stay or post-
operative recovery require clarification. There is
no doubt that in the proper setting, patients who
are properly educated, appropriately motivated,
and managed by surgeons and anesthesiologists
with experience in outpatient procedures, can
undergo laparoscopic cholecystectomy and com-
mence oral intake within hours of their operative
procedure, ambulate early, and be discharged to
their homes for recovery in a familiar environ-340 HPB INTERNATIONAL
ment either on the day of their operation or one
day later. The issue at hand now is to compare
laparoscopic cholecystectomy to "small-inci-
sion" cholecystegtomY in a properly designed
trial, in such a setting.
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Can Small Hepatocellular Carcinoma be Cured
by Percutaneous Acetic Acid Injection Therapy?
ABSTRACT
Ohishi, K., Nomura, F., Ito, S. and Fujiwara, K. (1996)
Prognosis of small hepatocellular carcinoma (less than 3cm)
after percutaneous acetic acid injection: Study of 91 cases.
Hepatology; 23, 994-1002.
To assess the efficacy of ultrasound (US)-guided
percutaneous acetic acid (in concentrations of 15%,
20%, 30%, 40%, and 50%) injection for small
hepatocellular carcinomas (HCCs) for long-term
prognosis, percutaneous acetic acid injection using
15% to 50% acetic acid was performed in 91 patients
with one to four HCCs smaller than 3 cm during the
past 6.5 years. During the series of treatment
sessions for each patient, the same concentration of
acetic acid was used. All tumors could be treated
successfully with percutaneous acetic acid injection
despite the differences in acetic acid concentration
used. The number of treatment sessions to treat
similar size of tumor was less when the higher
concentration of acetic acid was used. No serious
complications occurred as a direct sequela to
percutaneous acetic acid injection. None of the
tumor treated regrew. The 1-, 2-, 3-, 4-, and 5-year
survival rates for91 patients were 95%, 87%,80%, 63%,
and 49%, respectively. The 1-, 2-, 3-, 4-, and 5-year
cancer-free survival rates of these patients were 83%,
54%, 50%, 37%, and 29%, respectively. Both liver
function and size of tumor affected both survival rate
and cancer-free survival rate significantly, but the
number oftumors did not. The concentration of acetic
acid did not affect the survival rate. Percutaneous
acetic acid using 15% to 50% acetic acid will be
effective therapy for small HCCs for long-term
prognosis. (Hepatology 1996; 23, 994-1002).
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PAPER DISCUSSION
The study by Ohnishi et al. [1] recommended
that acetic acid is the preferred agent to absolute
alcohol because acetic acid has the property of